Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Free Cash Flow (2019 - 2025)

Benitec Biopharma's Free Cash Flow history spans 7 years, with the latest figure at $12.3 million for Q1 2025.

  • For Q1 2025, Free Cash Flow rose 297.97% year-over-year to $12.3 million; the TTM value through Mar 2025 reached -$3.3 million, up 83.69%, while the annual FY2024 figure was -$19.6 million, 8.69% down from the prior year.
  • Free Cash Flow for Q1 2025 was $12.3 million at Benitec Biopharma, up from -$7.7 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $12.3 million in Q1 2025 and bottomed at -$7.7 million in Q4 2024.
  • The 5-year median for Free Cash Flow is -$4.3 million (2021), against an average of -$3.5 million.
  • The largest annual shift saw Free Cash Flow crashed 158.78% in 2021 before it surged 297.97% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$3.3 million in 2021, then tumbled by 77.42% to -$5.9 million in 2022, then rose by 9.09% to -$5.3 million in 2023, then plummeted by 44.92% to -$7.7 million in 2024, then skyrocketed by 259.37% to $12.3 million in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Free Cash Flow are $12.3 million (Q1 2025), -$7.7 million (Q4 2024), and -$4.6 million (Q3 2024).